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Abstract
Here we introduce LOVTRAP, an optogenetic approach for reversible, light-induced protein 
dissociation. LOVTRAP is based on protein A fragments that bind to the LOV domain only in the 
dark, with tunable kinetics and a >150-fold change in Kd. By reversibly sequestering proteins at 
mitochondria, we precisely modulated the proteins’ access to the cell edge, demonstrating a 
naturally occurring 3 mHz cell edge oscillation driven by interactions of Vav2, Rac1 and PI3K.
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The ability to control proteins with light has been extended beyond engineering light-
controlled ion channels, to activatation of non-channel proteins through fusion with light-
sensitive plant proteins1. This has revealed important roles for transient subcellular 
localization and activation kinetics in signaling1. Here we describe LOVTRAP (LOV2 Trap 
and Release of Protein), an optogenetic approach capable of repeatedly and reversibly 
controlling protein activity with precise kinetics, and applicable to different proteins. The 
approach is based upon a small protein, which we named Zdark (Zdk), generated by mRNA 
display screening of a library derived from the Z subunit of protein A. Zdk binds selectively 
to the dark state of LOV2, a photo-sensor domain from Avena sativa phototropin 1. We 
anchored either Zdk or LOV2 away from the site where the protein of interest (POI) acted, 
and fused the POI to the non-anchored member of the pair (Fig. 1a). In the dark the POI was 
sequestered away from its site of action; upon irradiation, Zdk dissociated from LOV2, 
freeing the POI to move to its site of action. This approach improves upon previously 
available methods in several ways: important to the biological proof-of-principal studies 
described here, it provides diffusion limited activation kinetics (proteins are released in less 
than a second) and deactivation rates can be tuned from seconds to minutes using mutations 
described below. The approach is broadly applicable, as the POI simply needs to be fused to 
either LOV or Zdk. The method reduces ‘leakiness’, or dark state background activity: 
Anchored LOV2 can be expressed in excess of the POI, so that even if a small equilibrium 
amount of LOV2 is in the “lit”/nonbinding conformation in the dark, there is still sufficient 
anchored LOV2 to sequester the POI (Supplementary Note, Supplementary Fig. 1). Finally, 
proteins are not controlled through light-induced delivery to specific subcellular locations; 
hence they can act at multiple localizations upon activation.
Zdk was generated using a library based on the Z domain of immunoglobulin binding 
staphylococcal protein A2. The Z domain is a small, tightly folded three helix bundle. It 
contains no cysteines or disulfides that could be reduced and contribute to unfolding in cells. 
Thirteen residues along the first and second helices were randomized using an NNK codon2 
(Fig. 1b) to generate an mRNA-displayed protein library containing 5×1013 unique Z 
variants. After 12 rounds of selection, the enriched cDNA library was sequenced and the 
binding of 20 candidates with two consensus sequences were analyzed. Fig. 1c shows the 
binding properties of the three Zdk variants selected for further use. A radiometric binding 
assay showed that Zdk1, the candidate with the greatest difference in affinity for LOV’s lit 
versus dark states, had 26.2 nM affinity for a LOV2 mutant fixed in the dark state (C450A3), 
but Kd > 4 μM for a lit state mutant (I539E4) (Fig. 1c). A model based on this affinity 
showed that caging was optimal when the mitochondrial anchor was expressed at 5–10 fold 
excess over the other component (Fig. 1d). The crystal structure of LOV2 complexed with 
Zdk1 showed that LOV2’s C-terminal helix Jα, which unwinds upon irradiation5, was 
inserted into a pocket formed by the first two helices of Zdk1 (Fig. 1e, Supplementary Figs. 
2 & 3, Supplementary Table 1, Movie 1). Consistent with this crystal structure, mutations 
near the LOV2 C-terminus abolished binding, while mutations on other portions of the Jα 
helix had no effect (Supplementary Fig. 3). Zdk2 and Zdk3 showed smaller differences in lit/
dark affinity (Fig. 1c), and their binding did not require interaction with the LOV C-terminal 
helix (Supplementary Figs. 2 & 4, Supplementary Table 1). Zdk2 and Zdk3 will be useful in 
applications in which proteins must be appended to the LOV C-terminus.
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To examine the kinetics of protein activation and inactivation using LOVTRAP in living 
cells, the N-terminus of LOV2 was fused to mCherry fluorescent protein, and the N-
terminus of Zdk was fused to a fragment of TOM20, a mitochondrial anchoring sequence6. 
When the two proteins were co-expressed in HeLa cells, mCherry was localized at 
mitochondria in the dark, but generated diffuse cytoplasmic distribution within 1 second 
after irradiation with 450–490 nm light (Fig. 2a, Supplementary Fig. 4, Movie 2). Cycling 
between the lit and dark distributions at least 10 times showed no diminution of the release 
or return to the mitochondria (Fig. 2b). Use of LOV mutants incapable of undergoing light-
induced conformational changes showed only mitochondrial localization even after 
prolonged irradiation (Supplementary Fig. 5, Movie 3). Using wild type LOV2, the half-life 
for return of diffuse mCherry to the mitochondria was 18.5 seconds (Fig. 2c). These kinetics 
were tunable, using known and novel mutations of the LOV2 domain (Supplementary Table 
2)7, 8, enabling us to vary the t1/2 of return from 1.7 to 496 seconds (Fig 2c). Fast rates are 
useful to control signaling with precise kinetics, while slow kinetics enable continuous 
activation with minimal irradiation (eg for the V416L mutant, a 1 second light pulse every 
2.5 minutes will maintain greater than 80% activity). Finally we tested the ability of 
LOVTRAP to reversibly anchor the POI at points other than mitochondria; fusion of Zdk 
with an N-terminal fragment of Lyn kinase9 led to reversible translocation of LOV2 between 
the cytosol and plasma membrane (Fig. 2d, Movie 4).
Regulatory processes controlling cell edge protrusion and retraction are driven by feedback 
interactions among signaling proteins10, 11. At steady state, the cell edge oscillates on a time 
scale of 1 – 5 minutes12. We leveraged the kinetic control of LOVTRAP to mimic the 
activation and deactivation of signals that drive these oscillations, focusing on the GTPases 
Rac1 and RhoA, and their upstream GTP exchange factor Vav2. In order to control these 
proteins’ activity without influence from endogenous regulatory pathways, we fused Zdk to 
constitutively active mutants of RhoA (Q63L) and Rac1 (Q61L), and to a constitutively 
active fragment of Vav2 (aa 185-57513, Supplementary Table 3). In HeLa cells, release of 
each protein (henceforth referred to as protein “activation”) produced different effects on 
edge velocity, ruffling, cell area and protrusion distribution (Fig. 2e, f, g, h, i, and j, 
Supplementary Figs. 6, Movie 5, 6 and 7). Before irradiation, expression of LOVTRAP 
Vav2, LOVTRAP Rac1 and LOVTRAP RhoA had little effect on endogenous Rac1 
expression, cell edge protrusion or mitochondrial function (Supplementary Figs. 8,9,10 and 
11).
To further analyze the protrusion and retraction events induced by activation of Vav2, Rac1 
and RhoA we turned to morphodynamic profiling12, in which the cell edge was tracked 
before, during, and after optogenetic stimulation (Movie 8) and quantified the behavior in an 
edge velocity kymograph, where each row represents the velocity evolution of a particular 
location on the cell edge over time (Fig. 3a). Strikingly, activation of Vav2 did not just 
induce a spike of positive velocity, but instead generated a sustained increase in protrusion 
and retraction velocities. This suggested that an elevated state of Vav2 signaling contributes 
to both protrusion and retraction responses.
We suspected that frequency spectra of protrusion/retraction cycles would undergo changes 
during Vav2 activation and deactivation, as elevated Vav2 activity would gradually turn on 
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different downstream effector pathways with different response kinetics. We therefore 
implemented the Hilbert-Huang transform14 to define for each location along the cell edge 
an instantaneous frequency density spectrum (see Methods, Supplementary Fig. 12). Spectra 
from all locations were integrated into a per-cell spectrogram (Fig. 3b, left), and temporally 
averaged for the periods before, during, and after Vav2 activation (Fig. 3b, right). Before and 
after activation the spectra displayed a uni-modal distribution with a peak at ~0.5 mHz, 
corresponding approximately to the inverse of the 1800 sec long time window of 
observation. Upon Vav2 activation, a peak emerged at 2.9 mHz, reflecting a global 
stimulation of protrusion-retraction-protrusion cycles of ~330 sec duration. Owing to the 
regularity of this response across a cell population we hypothesized that ~3 mHz reflected 
the principal frequency of a resonator.
To test this we exploited the kinetic control and rapid reversibility of LOVTRAP-Vav2 to 
optogenetically entrain oscillatory cycles. Indeed, we found that pulses of blue light of 50 s 
‘on’ and 250 s ‘off’ generated highly synchronized protrusion-retraction cycles with a 3.3 
mHz frequency (Fig. 3c and Supplementary Fig. 13a). Further support for the resonator 
hypothesis came from the observation that cycles could not be entrained when exposing 
LOVTRAP-Vav2 to pulses of 50 s ‘on’ and 200 s ‘off’ (4 mHz), whereas pulses of 6.7 mHz 
and 10.0 mHz, i.e. multiples of the putative principal resonator frequency, did entrain cycles, 
but again at 3.3 mHz (Fig. 3c and Supplementary Fig. 13b). Of note, in all experiments we 
observed several peaks at frequencies below 3.3 mHz. These may be the product of 
secondary resonating circuits or represent lower harmonics of the primary resonator, such as 
the peaks at 1.1 mHz.
Our data suggested Vav2 is part of an activator circuitry that stimulates protrusion, most 
probably through its role as an activating GEF of Rac1 GTPase, which drives actin filament 
assembly and lamellipodium formation15 (Supplementary Fig. 14). To test this we used a 
LOVTRAP construct to acutely release Rac1Q61L and performed spectral analysis (Fig. 3d 
and Supplementary Fig. 13c). Compared to the Vav2-response, the Rac1-induced 
oscillations showed a mild frequency density increase between 3 mHz and 4 mHz. The 
absence of a resonator response could relate to the fact that the activity of RacQ61L cannot 
be modulated by GTPase-regulatory pathways, which might be essential for the restoring 
circuitry. Therefore, we repeated these experiments by producing a LOVTRAP-construct for 
the Rac1-specific GEF Tiam1. Acute release of Tiam1 also had no effect on the spectra (Fig. 
3d and Supplementary Fig. 13c). Hence, activation of cells with Vav2 promotes both the 
stimulation and the restoration required for cyclic protrusion and retraction.
Vav2 interacts with phospholipid products of the phosphoinositide (PI) 3-kinase15, 16. These 
are thought to localize at the protruding cell edge via association of PI3K with focal 
adhesions17 and/or via direct or indirect activation of PI3K downstream of Rho-family 
GTPases18, 19. Therefore, we tested whether inhibition of PI3K would abolish the protrusion 
- retraction resonator. We found no resonance when we irradiated cells expressing 
LOVTRAP-Vav2 if the medium contained the PI3K inhibitor LY294002 (Fig. 3d and 
Supplementary Fig. 13c). To further test this model, we used a LOVTRAP-Vav2 construct 
harboring a point mutation of Vav2’s PH domain that lowers interaction with lipid 
products20. Intriguingly, although optogenetic release of this construct stimulated 
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protrusion-retraction cycles over a broad range of frequencies, the narrow-band resonance 
observed with wildtype Vav2 was gone (Fig. 3d and Supplementary Fig. 13c).
LOVTRAP uses the new Zdk reagents in a simple and versatile approach that can be applied 
to many proteins. Protein release occurs with subsecond kinetics and reversibility can be 
tuned from <3 to ~500 seconds. The Zdk reagents can be building blocks for other 
optogenetic tools, providing light-induced dissociation with > 150-fold change in affinity. 
LOVTRAP’s precise and reversible control of activation kinetics was used to explore a 
signaling circuit that governs cell edge oscillations, revealing a natural resonance frequency 
and an essential role for Vav2. We anticipate that in a similar manner LOVTRAP can shed 
light on the host of processes that rely on oscillating cellular signals.
ONLINE METHODS
Z-LIBRARY CONSTRUCTION
The synthetic gene encoding the Z library was assembled by annealing and enzymatically 
extending primers ZL-U141 and ZL-B143 (Supplementary Table 4, Genelink, NY) that have 
complementary 3′ ends. Codon NNK (N=G, A, C, T; K=G, T) was used to encode 
randomized residues. The resulting dsDNA was amplified by PCR using primer ZL-5-66 
and ZL-3-57 (Supplementary Table 4). The cycle numbers were optimized to avoid over-
amplification by running small scale PCR reactions and checking the product from different 
cycles on 2% agarose gels. A small portion of the final cDNA library was cloned into 
pJet1.2 vector (Thermo Scientific) and transformed into NEB5α competent cells. 95 
colonies were picked and sequenced to check the codon bias.
mRNA DISPLAY
The C450A and I539E mutants of the LOV2 domain of Avena sativa (oat) phototropin1 
(404-546) were cloned into the bacterial expression vector pProEx-HTb containing N-
terminal His6-tag followed by an Avi-tag. The proteins were expressed in E. coli strain 
CVB101 (Avidity). They were induced using 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG, sigma) with 100 μM Biotin (Sigma) to express biotinylated 
LOV2 proteins, or with 0.5 mM IPTG without Biotin to express unbiotinylated LOV2 
proteins. The proteins were purified using a HisTrap FF column (GE Healthcare).
The mRNA-protein fusion library was generated and purified according to our published 
protocol.21 Reverse transcription was performed to convert the mRNA-protein into cDNA/
mRNA-protein form. The purified fusion library was diluted in a binding buffer (50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20, 1 mg/mL BSA, 1 mg/mL yeast tRNA 
and 0.5 mM EDTA) and passed through 75 μL Streptavidin UltraLink Plus Resin (Thermo 
Scientific) pretreated with 1 mg/mL BSA and 1 mg/mL yeast tRNA to minimize the 
sequences that nonspecifically bound to streptavidin and/or the matrix. The flowthrough was 
incubated with LOV2 C450A pre-immobilized on 75 μL streptavidin beads for 90 minutes at 
room temperature. In rounds 1–5, the beads were washed with 300 μL washing buffer (50 
mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20), while in the rounds 6–12, the beads 
were washed with 300 μL washing buffer containing 5 mg/mL LOV2 I539E to minimize the 
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enrichment of sequences that bound to the lit form of LOV2, followed by a wash with 300 
μL washing buffer. In rounds 1–5, the selected library was eluted by incubating the beads 
with 150 μL eluting buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween-20, 1.5 
mM MgCl2) contains 1 U RNase H (Thermo Scientific) for 120 minutes at 37°C, while in 
the rounds 6–12, the selected library was competitively eluted by incubating the beads with 
300 μL eluting buffer containing 5 mg/mL LOV2 C450A for 60 minutes at room 
temperature. The elution was treated with 1 U protease K for 60 minutes at room 
temperature, followed by phenol/chloroform extraction to remove protein components. The 
enriched cDNA library was regenerated by PCR using primers ZL-5-66 and ZL-3-57.
After 12 rounds of selection, the enriched DNA library was cloned into the pJet1.2 vector 
and transformed into DH5α. 120 colonies were picked for sequencing.
RADIOMETRIC BINDING ASSAY
The sequences from the selected library were translated in vitro in the presence of 35S-
Methonine, followed by purtification using HisPur Cobalt Resin (Thermo Scientific). The 
purified proteins were incubated with different concentrations of biotinylated LOV2 mutants 
in 96-well filter plates (Pall) at room temperature for 30 minutes. 20 μL Streptavidin 
UltraLink Plus Resin was added and the suspension was shaken for 60 minutes. The 
flowthrough was removed and the beads were washed with 3 bed volumes of washing buffer. 
200 μL scintillation liquid was added in each well and the top of the plate was sealed using a 
transparent sealer. The plate was rotated to mix well, then read using a scintillation plate 
reader.
BIO-LAYER INTERFEROMETRY (BLI) ASSAY
GST-Zdk1 protein and LOV2 w.t. were expressed and purified as described above. LOV_3, 
LOV_4 and LOV_5 proteins were gifts from Dr. Brian Kuhlman. The binding kinetics were 
determined using an Octet QKe system (forteBio). Anti-GST biosensors were equilibrated in 
an assay buffer (phosphate-buffered saline with 1 mg/ml BSA and 0.05% Tween-20) for 60 
seconds, then the tips were loaded with 100 nM GST-Zdk1 for 300 seconds. The association 
and dissociation of LOV2 proteins were examined by incubating the Zdk-loaded tips with 
50, 100, 200 and 500 nM LOV2 proteins for 300 seconds and then in assay buffer for 300 
seconds. Kinetics data were analyzed using forteBio software (forteBio). The curves were fit 
globally using a 1:1 model.
PROTEIN CRYSTALLIZATION
The C450A mutant of the LOV2 domain of Avena sativa (oat) phototropin1 (404-546) was 
cloned into the bacterial expression vector pGEX (GE Healthcare) containing an N-terminal 
GST-tag and His6-tag followed by a TEV protease cleavage site. The Zdk1, Zdk2 and Zdk3 
proteins were cloned into pQE-80L (Qiagen) containing an N-terminal His6-tag followed by 
a TEV protease cleavage site. The proteins were purified using a HisTrap FF column (GE 
Healthcare).
After elution from the HisTrap FF column using a linear gradient of 10–500 mM imidazole 
in the same buffer, the proteins were mixed with TEV protease using a 1:20 molar ratio of 
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TEV:substrate and dialyzed overnight at 4 °C against TEV buffer (50 mM Tris-HCl pH 7.5, 
100 mM NaCl, 1 mM dithiotreitol). The dialyzed sample was loaded onto the HisTrap FF 
column to remove cleaved GST-/His6-tag and His6-TEV. The flow-through was concentrated 
and subjected to gel filtration chromatography on a Superdex 75 column (GE Healthcare) 
equilibrated with TEV buffer. The eluted protein was concentrated, aliquoted, frozen in 
liquid nitrogen and stored at −80 °C.
Crystallization was performed at 20 °C in the dark using the vapor-diffusion method. Crystal 
handling was done under orange light with a 2 mm thick OG570 filter (Schott, Germany) 
shielding the microscope bulb. To allow complex formation of LOV2(C450A) and Zdk1 
both proteins were incubated for 60 min in a 1:1 molar ratio in washing buffer. The 
complexes of LOV2(C450A) with Zdk2 or Zdk3 were formed by mixing both components 
in a 1:1 stoichiometry and incubating for 30 min on ice. Crystals of LOV2-Zdk1 were 
obtained by mixing equal volumes of protein solution (at 10.0 mg/ml) with 2 M (NH4)2SO4, 
0.1 M sodium citrate pH 3.5 reservoir solution. Tetragonal crystals of the LOV2-Zdk1 
complex grew to final dimensions within 1 week. For cryoprotection, crystals were 
transferred to reservoir solution containing 25% (v/v) glycerol and, after 1-min incubation, 
crystals were cryocooled in liquid nitrogen. Box-shaped crystals of LOV2-Zdk2 complex 
were grown by mixing equal volumes of preformed protein complex solution (at 15.7 mg/
ml), reservoir solution containing 0.1 M tri-sodium citrate pH 5.6, 0.2 M ammonium acetate, 
32% (w/v) PEG 4000 and 0.1 M copper(II) chloride solution as an additive. Before flash-
cooling in liquid nitrogen the crystals were briefly washed in cryoprotectant solution 
consisting of the reservoir solution with PEG 4000 concentration increased to 40% (w/v). 
Rod-shaped crystals of LOV2-Zdk3 complex were obtained by mixing equal volumes of 
preformed protein complex solution (at 16.5 mg/ml) and reservoir solution containing 0.1 M 
citric acid pH 4.0, 1.0 M lithium chloride, 18% (w/v) PEG 6000. Crystals were briefly 
rinsed in cryoprotectant solution composed of the corresponding reservoir solution 
supplemented with 20% (v/v) glycerol prior to flash-cooling in liquid nitrogen.
X-RAY DIFFRACTION DATA COLLECTION AND STRUCTURE DETERMINATION
Single crystal X-ray diffraction data were collected at 100 K on the X10SA beamline at the 
Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland). The data were processed 
with XDS.22 All three structure of LOV2-Zdk complexes were determined by molecular 
replacement using Phaser23. The structure of LOV2-Zdk1 was determined with individual 
search models of LOV2 (PDB entry 2V0U) and protein Z (PDB entry 1LP1, chain A). A 
unique solution was obtained for one molecule each in the asymmetric unit. However, initial 
density maps suggested the presence of another protein Zdk1 molecule with altered N-
terminal helix conformation that was manually added during the initial rounds of refinement. 
The structure of LOV2-Zdk2 complex was determined using LOV2 domain coordinates 
from PDB entry 2WKQ and a homology model of Zdk2 (residues 9-58) generated with 
SWISS-MODEL24 based on PDB entry 2KZJ as a search models. The structure of LOV2-
Zdk3 complex was determined using the same LOV2 coordinates and a homology model of 
Zdk3 (residues 9-58) based on PDB entry 1Q2N. The final models were optimized in 
iterative cycles of manual rebuilding using Coot25 and refinement using phenix.refine26. 
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Data collection and refinement statistics are summarized in Supplementary Table 5. Model 
quality was validated using validation methods implemented in PHENIX27.
PLASMID CONSTRUCTION AND TRANSFECTION
All plasmids were generated by overlap PCR and subcloned into mammalian expression 
vector pTriEx by restriction enzyme digestion and ligation. The plasmids (Supplementary 
Table 6) were co-transfected into the cells using FuGene 6 (Promega), following the 
manufacturer’s instructions.
CELL LINES
All cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, 
Virginia) and were tested for mycoplasma by the UNC Tissue Culture Core Facility. No cells 
on the ICLAC list of commonly misidentified cells were used in this work.
WESTERN BLOTTING
HeLa cells were transiently co-transfected with LOVTRAP plasmids for 20 hours before 
lysis in RIPA buffer. The cell extracts were adjusted to the same amount of total cellular 
protein (50 μg), and electrophoresed in a 4% to 15% gradient polyacrylamide gel. After 
electrophoretic transfer to a PVDF membrane at 1.0A for 30 min, the membranes were 
blocked with TBST (10mM Tris-HCl, pH7.5, 150mM NaCl, 0.05%Tween-20) containing 
5% BSA for 1 hour at room temperature. The primary antibodies (mouse monoclonal anti-
Rac1 antibody from Cytoskeleton, Inc., Cat. # ARC03, 1:500 dilution28; mouse monoclonal 
anti-GFP Antibody from Clontech, Cat# 632381, 1:1000 dilution29; and mouse monoclone 
anti-human vinculin antibody Clone h-VIN1 from Sigma, Cat# V9131, 1:200 dilution30) in 
TBST were placed on the membrane and incubated at 4°C overnight. After three washings 
with TBST over 5 min, the second antibody (Anti-mouse IGG, conjugated with DyLight680, 
from Cell Signaling, Cat#5470P, 1:10,000 dilution31) was applied. After three washings with 
TBST over 5 min, the membrane was scaned by the Odyssey® Infrared Imaging System 
(LI-COR Biosciences, Lincoln, NE).
FLOW CYTOMETRY
HeLa cells were transiently co-transfected with LOVTRAP plasmids for 20 hours, then 
rinsed, trypsinized, washed and resuspended in fresh DPBS buffer at a density of 106 
cells/ml. 5 μM DilC1(5) or MitoSOX Red were added to the cells, and the cells were then 
incubated at 37°C for 30min according to Mukhopadhyay et al32. Samples were analyzed 
using an LSR II flow cytometer (BD Biosciences) at the UNC Flow Cytometry Core 
Facility. The gate was set so that only cells labeled with dyes were displayed.
LIVE CELL IMAGING
HeLa cells were transiently co-transfected with LOVTRAP plasmids 20 – 28 hours before 
imaging. Cells used for live cell imaging were seeded on coverslips coated with 10 mg/ml 
fibronectin in Ham’s F-12K medium free of Phenol Red and containing 0.5% FBS. 
Coverslips were mounted in an Attofluor live cell chamber (Invitrogen) and placed on a 
heated microscope stage (Warner). Images were acquired using an Olympus IX81-ZDC 
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microscope equipped with a CoolSNAP HQ2 14-bit camera (Photometrics). Bandpass and 
neutral density filters (Chroma) were switched using motorized filter wheels (Ludl 
Electronic Products) controlled by Metamorph Software version 7.6.4. YFP and mCherry 
images were acquired using a 100 W Hg arc lamp with a 1% ND filter and a 510–520 nm or 
565–595 nm band-pass filter respectively, for 500 ms. For photoactivation, a 5% ND filter 
and a 426–446 nm band-pass filter were used. Unless otherwise indicated, activation was 
carried out using a pulse protocol alternating 5 seconds light with 5 seconds dark. This 
minimizes photodamage while maintaining greater than 80% activity for wild type LOV2. 
Images were processed post acquisition via shading correction, background subtraction, and 
binary masking using Metamorph software (Molecular Devices).
BLIND SCORING
Images from VAV2 or RhoA activation were mixed with images from control cells and a 
naïve observer was asked to score the cells, stating whether the blue light induced or reduced 
ruffling.
IMAGE ANALYSIS
Cell outlines were identified using intensity based thresholding on all frames of time lapse 
movies (Movie 8). The cell edge was subsequently divided into 1μm segments, or windows, 
where the average normal velocity vector was calculated by tracking these segments from 
one frame to the next. A velocity profile for each window was built using the signed normal 
vector magnitude of the respective window. The cell edge velocity map (as shown in the 
main text, figure 3a) was constructed by stacking up the velocity profiles from all windows, 
as described in Vilela et al., 201333.
EDGE VELOCITY FREQUENCY ANALYSIS
A signal processing technique known as Hilbert-Huang transform was used to analyze the 
time-frequency content of the edge velocity profiles over time 14. In a first step this 
technique applies the empirical mode decomposition algorithm (EMD) to decompose the 
signal into monochromatic components (components with only one frequency at each time 
point). Supplementary Fig. 13 shows an example, in which a test signal is decomposed into 
eight empirical modes. Subsequently, each mode is Hilbert transformed and used to build a 
mathematical construct referred to as a Hilbert Spectrum. Two important features were 
inferred from the spectrum at all time points of a time series: the instantaneous frequency 
spectrum defined by the combination of frequencies of the monochromatic modes and their 
respective amplitudes. The final time series spectrum was obtained by arranging 
instantaneous frequencies and amplitudes over time for all decomposed components, as 
shown in Supplementary Fig. 13 box.
Each signal extracted from a window of a given cell gave rise to one time-frequency 
spectrum. The spectrum for a given cell was then obtained by bootstrapping the mean 
amplitude for each time-frequency pair of all windows34 (Supplementary Fig. 13 flowchart). 
The same bootstrapping procedure was applied to obtain a final spectrum extracted from 
several cells. To allow combination of cells with different ranges of protrusion/retraction 
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velocity each individual cell spectrum was first normalized. A specific bootstrap technique 
for frequency domain data was used to avoid bias from dominant cells or cell windows 14.
CODE AVAILABILITY
Software codes developed for cell protrusion tracking and spectral analysis will be made 
available through the Danuser lab website. In particular, the protrusion tracking methods are 
included in a larger package for the analysis of cell signaling dynamics that is currently in 
revision for a separate publication.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was funded by the NIH grants R01-GM090317 (K.M.H. and G.D.), P01-GM103723 (K.M.H. and G.D.), 
R01-DA036877 (K.M.H.), R01-CA157738 (R.L.), and by the Max Planck Society, German Research Foundation 
DFG, FOR 1279 (I.S.). HW is a recipient of an Arthritis Foundation Postdoctoral Fellowship. We thank Elisabeth 
Hartmann for crystallizing Zdk-LOV complexes, Ryan Littlefield for providing LOV2 peptides, and Evan Trudeau 
for cloning help. Diffraction data were collected at the Swiss Light Source, beamline X10SA, of the Paul Scherrer 
Institute, Villigen, Switzerland. We thank the Heidelberg data collection team and the PXII staff for their support in 
setting up the beamline and Chris Roome for expert support of the crystallographic software. The UNC Flow 
Cytometry Core Facility is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC 
Lineberger Comprehensive Cancer Center.
References
1. Weitzman M, Hahn KM. Optogenetic approaches to cell migration and beyond. Curr Opin Cell Biol. 
2014; 30:112–120. [PubMed: 25216352] 
2. Nord K, et al. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial 
receptor domain. Nat Biotechnol. 1997; 15(8):772–7. [PubMed: 9255793] 
3. Kay CW, et al. Blue light perception in plants. Detection and characterization of a light-induced 
neutral flavin radical in a C450A mutant of phototropin. J Biol Chem. 2003; 278(13):10973–82. 
[PubMed: 12525505] 
4. Harper SM, Christie JM, Gardner KH. Disruption of the LOV-Jalpha helix interaction activates 
phototropin kinase activity. Biochemistry. 2004; 43(51):16184–92. [PubMed: 15610012] 
5. Harper SM, Neil LC, Gardner KH. Structural basis of a phototropin light switch. Science. 2003; 
301(5639):1541–4. [PubMed: 12970567] 
6. Kanaji S, et al. Characterization of the signal that directs Tom20 to the mitochondrial outer 
membrane. J Cell Biol. 2000; 151(2):277–88. [PubMed: 11038175] 
7. Zoltowski BD, Vaccaro B, Crane BR. Mechanism-based tuning of a LOV domain photoreceptor. 
Nat Chem Biol. 2009; 5(11):827–34. [PubMed: 19718042] 
8. Kawano F, et al. Fluorescence imaging-based high-throughput screening of fast- and slow-cycling 
LOV proteins. PLoS One. 2013; 8(12):e82693. [PubMed: 24367542] 
9. Levskaya A, et al. Spatiotemporal control of cell signalling using a light-switchable protein 
interaction. Nature. 2009; 461(7266):997–1001. [PubMed: 19749742] 
10. Krause M, Gautreau A. Steering cell migration: lamellipodium dynamics and the regulation of 
directional persistence. Nat Rev Mol Cell Biol. 2014; 15(9):577–90. [PubMed: 25145849] 
11. Vicente-Manzanares M, Webb DJ, Horwitz AR. Cell migration at a glance. J Cell Sci. 2005; 118(Pt 
21):4917–9. [PubMed: 16254237] 
12. Machacek M, Danuser G. Morphodynamic profiling of protrusion phenotypes. Biophys J. 2006; 
90(4):1439–52. [PubMed: 16326902] 
Wang et al. Page 10
Nat Methods. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
13. Abe K, et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem. 2000; 275(14):10141–
9. [PubMed: 10744696] 
14. Huang, NE.; Shen, SS. Interdisciplinary Mathematical Sciences. 2. Hackensack New Jersey: World 
Scientific; 2014. Hilbert-Huang transform and its applications; p. xiip. 386
15. Hornstein I, Alcover A, Katzav S. Vav proteins, masters of the world of cytoskeleton organization. 
Cell Signal. 2004; 16(1):1–11. [PubMed: 14607270] 
16. Han J, et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related 
guanosine triphosphatases by Vav. Science. 1998; 279(5350):558–60. [PubMed: 9438848] 
17. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate 
phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1994; 91(21):10148–52. [PubMed: 
7937853] 
18. Weiner OD, et al. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates 
neutrophil polarity. Nat Cell Biol. 2002; 4(7):509–13. [PubMed: 12080346] 
19. Yang HW, et al. Cooperative activation of PI3K by Ras and Rho family small GTPases. Mol Cell. 
2012; 47(2):281–90. [PubMed: 22683270] 
20. Booden MA, Campbell SL, Der CJ. Critical but distinct roles for the pleckstrin homology and 
cysteine-rich domains as positive modulators of Vav2 signaling and transformation. Mol Cell Biol. 
2002; 22(8):2487–97. [PubMed: 11909943] 
21. Cotton SW, et al. Selection of proteins with desired properties from natural proteome libraries 
using mRNA display. Nat Protoc. 2011; 6(8):1163–82. [PubMed: 21799486] 
22. Kabsch W, Xds. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 2):125–32. [PubMed: 20124692] 
23. McCoy AJ, et al. Phaser crystallographic software. J Appl Crystallogr. 2007; 40(Pt 4):658–674. 
[PubMed: 19461840] 
24. Arnold K, et al. The SWISS-MODEL workspace: a web-based environment for protein structure 
homology modelling. Bioinformatics. 2006; 22(2):195–201. [PubMed: 16301204] 
25. Emsley P, et al. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 
66(Pt 4):486–501. [PubMed: 20383002] 
26. Afonine PV, et al. Towards automated crystallographic structure refinement with phenix.refine. 
Acta Cryst. 2012; D68(Pt 4):352–67.
27. Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure 
solution. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 2):213–21. [PubMed: 20124702] 
28. Seidelin JB, et al. Cellular inhibitor of apoptosis protein 2 controls human colonic epithelial 
restitution, migration, and Rac1 activation. Am J Physiol Gastrointest Liver Physiol. 2015; 
308(2):G29–9.
29. Lorenz H, Hailey DW, Lippincott-Schwartz. Fluorescence protease protection of GFP chimeras to 
reveal protein topology and subcellular localization. J Nature Methods. 2006; 3:205–210.
30. Risse P, et al. Interleukin-13 inhibits proliferation and enhances contractility of human airway 
smooth muscle cells without change in contractile phenotype. American Journal of Physiology - 
Lung Cellular and Molecular Physiology. 2011 Jun 01.
31. Jia L, et al. Defining pathways of spindle checkpoint silencing: functional redundancy between 
Cdc20 ubiquitination and p31(comet). Mol Biol Cell. 2011 Nov; 22(22):4227–35. [PubMed: 
21937719] 
32. Mukhopadhyay P, et al. Simultaneous detection of apoptosis and mitochondrial superoxide 
production in live cells by flow cytometry and confocal microscopy. Nat Protoc. 2007; 2(9):2295–
301. [PubMed: 17853886] 
33. Vilela M, et al. Fluctuation analysis of activity biosensor images for the study of information flow 
in signaling pathways. Methods Enzymol. 2013; 519:253–76. [PubMed: 23280114] 
34. Zoubir, AM.; Iskander, DR. Bootstrap Techniques for Signal Processing. Cambridge, England; 
New York: Cambridge; 2004. p. xivp. 217
Wang et al. Page 11
Nat Methods. Author manuscript; available in PMC 2017 January 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Generation of Zdk and design of LOVTRAP
(a) LOV2 is anchored to the mitochondrial outer membrane. The protein of interest (POI) is 
attached to Zdk, a reagent that binds selectively to the dark state of LOV2. The POI is 
sequestered at mitochondria in the dark and released when cells are irradiated. (b) Thirteen 
residues along the first and second helices of the Z domain from protein A were randomized 
to generate a variable surface (left). Two consensus sequences bound specifically to the dark 
state of LOV2 (right). (c) Binding of Zdk isoforms to LOV2’s dark state (C450A mutant) 
versus lit state (I539E mutant) (n=4 for each curve). Dark versus lit affinities of Zdk1 
(black), Zdk2 (red) and Zdk3 (blue) were 26.2±2.2 nM/>4 μM, 17.0±3.9 nM/761±78 nM, 
and 11.4±3.6 nM/537±37 nM, respectively. Error bars are the s.d. of replicates. (d) The 
amount of protein released upon irradiation depends upon the relative expression levels of 
the mitochondrial anchor and the POI. This model shows the effects of using Zdk1 on the 
POI and LOV2 at the mitochondria (red), or vice-versa (blue). Optimal response is seen 
when the protein attached to the mitochondria is in 4–10 fold excess over the POI. LOV2 on 
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the mitochondria produces less free POI in the dark, and Zdk on mitochondria leads to more 
complete release. (e) Crystal structure of the LOV2-Zdk1 complex. Zdk1 (magenta) docks 
on the core domain of LOV2 (green) and the C-terminal residues of the LOV2 Jα helix 
(blue).
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Figure 2. Protein control by LOVTRAP
(a) Zdk1 was attached to the outer membrane of mitochondria and mCherry was attached to 
LOV2. Monitoring fluorescence intensity at a spot away from mitochondria (circle) revealed 
release and return kinetics (blue = irradiation). (b) Repeated irradiation cycles. (c) Effects of 
LOV2 mutants on return t1/2: I427T (purple, n=18) 1.7±0.6; V416T (green, n=12) 5.0±2.0; 
I427V (blue, n=15): 5.5±0.8; wild type (black, n=12) 18.5±3.7; V416I (orange, n=3) 239±5; 
V416L (red, n=6) 496±38. (d) HEK293 cells with LOV2 attached to the plasma membrane 
and Zdk attached to mCherry. Fluorescence monitored as in (a). (e) Reversible cell 
protrusion produced by light-induced release of constitutively active Vav2. (f) Cell area 
before, during and after light-induced release of constitutively active Vav2 (7 cells), Rac1 (7 
cells), RhoA (4 cells) and Control (5 cells). Wilcoxon rank test and permutation test were 
performed to the medians before and during irradiation. For both, p < 1e-6. (g) Light-
induced release of constitutively active Rac1 reversibly increases velocity. Dark blue line 
indicates median, band indicates 95% confidence interval, n=2017 edge locations from m = 
7 cells. (h) Release of constitutively active RhoA led to irreversible contraction and 
reversible decrease in ruffling. (i) Quantitation of Vav2 effects on ruffling. White = percent 
cells in which ruffling was induced, blue = percent cells with no obvious effect on ruffling. 
Cells were transfected either with LOVTRAP (Vav2, n=14) or with LOV and Zdk1 only 
(Control, n=18). (j) Inhibition of ruffling by RhoA(Q63L), graphed as in i. Control = 
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expression of LOV2 and Zdk1 only (n= 9), RhoA = LOVTRAP (n= 18). All scale bars 10μm 
except 1(a) lower = 1μm.
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Figure 3. Resonance in HeLa cell protrusion-retraction cycles upon acute release of Vav2
(a) Kymograph of cell edge velocity (y-axis, distance along cell perimeter; x-axis, time) (left 
panel). Time series of instantaneous edge velocity sampled at one cell edge location (right 
panel), indicated in the left panel by a white horizontal line. Red area, noise band as 
determined by empirical mode decomposition of the time series (see Methods). Blue lines at 
the top of each panel show the timing and duration of irradiation. (b) Left, representative 
spectrogram of HeLa cell protrusion cycles in response to Vav2 release (blue line indicates 
irradiation). Right, power density as a function of the temporal frequency of cell edge 
protrusion-retraction cycles, separated into before (blue), during (red), and after (gray) 
release of Vav2. Center line indicates median density, band indicates 95% confidence 
interval about median, calculated from n=2606 edge locations sampled in m=7 cells. (c) 
Power densities from cells stimulated with 3.3mHz, 4mHz, 6.7mHz and 10mHz blue light 
pulses. Center line and confidence bands as in B. (for each panel, n = 2044 edge locations 
sampled in m = 6 cells). (d) Changing power densities during acute stimulation of 
constitutively active Rac1Q61L (n=357 edge locations, m=2 cells), endogenous Rac1 via 
release of TIAM-1 DH/PH domain (n=1546 edge locations, m=4 cells), constitutively active 
Vav2 in the presence of the PI3K inhibitor LY294,002 (n=2350 edge location, m=7 cells), 
and Vav2 K401A mutant with impaired binding to PI3K-generetaed phospholipid products 
(n=1439 edge locations, m=4 cells).
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